About Us
Bosnalijek is the largest industrial manufacturer of medicines in Bosnia and Herzegovina, established in 1951.
Our success is the result of deliberate strategy and joint efforts targeted at the company’s development.
Our success is the result of deliberate strategy and joint efforts targeted at the company’s development.
Press Centre
Bosnalijek is the largest industrial manufacturer of medicines in Bosnia and Herzegovina, established in 1951.
Our success is the result of deliberate strategy and joint efforts for the Company’s development.
Our success is the result of deliberate strategy and joint efforts for the Company’s development.
News
NOTICE/RE-CONVENING REGULAR ANNUAL ASSEMBLY
Notice on re-convening Regular Annual Shareholders Assembly of Bosnalijek JSC
Pursuant to Article 55 paragraph (2) and (3) of Statute of Bosnalijek JCS (consolidated text No: 2830/2017 of 18.09.2017) and Article 233 paragraph (1) and (2) of Law on Companies (Official Gazette of Federation of BH No. 81/15 and 75/21), and based on the Supervisory Board's Decision No: 2448/22 of 2 July 2022, we hereby announce:
MORE
NOTICE/RE-CONVENING REGULAR ANNUAL ASSEMBLY
Notice on re-convening Regular Annual Shareholders Assembly of Bosnalijek JSC
Pursuant to Article 55 paragraph (2) and (3) of Statute of Bosnalijek JCS (consolidated text No: 2830/2017 of 18.09.2017) and Article 233 paragraph (1) and (2) of Law on Companies (Official Gazette of Federation of BH No. 81/15 and 75/21), and based on the Supervisory Board's Decision No: 2448/22 of 2 July 2022, we hereby announce:
Read more
ANNUAL REGULAR ASSEMBLY
NOTICE ON CONVENING ANNUAL REGULAR ASSEMBLY OF BOSNALIJEK JSC
Pursuant to Article 48 paragraph (1) and (2) of Statute of Bosnalijek JCS (consolidated text No: 2830/2017 of 18.09.2017) and Article 230 paragraph (1) of Law on Companies (Official Gazette of FB&H, No. 81/15), and based on the Supervisory Board's Decision on Convening Annual Regular Assembly No: 2112/22 of 31 May 2022, we hereby announce:
Read more
Previous news
NOTICE ON CONVENING AN EXTRAORDINARY SESSION OF THE GENERAL ASSEMBLY OF ...
Notice on reconvening of regular annual shareholders’ Assembly of Bosnal ...
Notice of convening annual regular assembly of Bosnalijek joint stock co ...
REPORT BY VOTING COMMITTEE
Notice of convening annual regular assembly of Bosnalijek d.d.
Bosnalijek Opens New Facility for Manufacturing Liquid and Semisolid Pha ...
Two Bosnalijek Teams Won Valuable Prizes at Dolorex B2B Night Relay Race ...
Notice of convening annual regular assembly of Bosnalijek joint stock co ...
Professional Lecture for Doctors and Patients Held On the Occasion of th ...
Bosnalijek signs cooperation agreement with Mylan, a global healthcare c ...
Bosnalijek Appoints US Major General David L. Grange (Ret.) as the Board ...
The Third Congress of Pharmacists from Montenegro held in Bečići
Foreign markets recognize the quality of our products
Bosnalijek won the prestigious industry award
Bosnalijek is again the best employer in the pharmaceutical sector in 20 ...
Successful Two-Day Roundtable of Psychiatrists Held
“Global Enterofuryl® Speaker Training – GEST” conference gathers nationa ...
4th “Acute Coronary Syndrome” training for 60 young doctors
A successful year for Bosnalijek, revenue up by 10 percent
Third Generation of American Yale University Students Visits Bosnalijek